BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16273111)

  • 21. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas.
    Yamada K; Takahashi M; Ogura M; Kagami Y; Taji H; Kamiya Y; Sugiura H; Morishima Y
    Bone Marrow Transplant; 2007 Apr; 39(8):471-6. PubMed ID: 17334381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: a long-term follow-up single-center study.
    Diaz MA; Lassaletta A; Perez A; Sevilla J; Madero L; Gonzalez-Vicent M
    Pediatr Hematol Oncol; 2010 May; 27(4):272-82. PubMed ID: 20426518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications in long-term survivors of Ewing sarcoma.
    Fuchs B; Valenzuela RG; Inwards C; Sim FH; Rock MG
    Cancer; 2003 Dec; 98(12):2687-92. PubMed ID: 14669290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
    Briccoli A; Rocca M; Salone M; Palmerini E; Balladelli A; Ferrari C; Di Fiore M; Bacci G
    J Surg Oncol; 2009 Sep; 100(3):222-6. PubMed ID: 19548266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J; Mrácek J; Havlas V; Trc T
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
    Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ewing's sarcoma: prognosis and survival in Mexican children from a single institution.
    Cárdenas-Cardós R; Rivera-Luna R; López-Facundo NA; Leal-Leal C; Gómez-Martínez R; Castellanos-Toledo A
    Pediatr Hematol Oncol; 1999; 16(6):519-23. PubMed ID: 10599091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
    J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
    Yonemoto T; Tatezaki S; Ishii T; Satoh T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
    Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
    Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.
    Rosenthal J; Pawlowska AB
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):251-62. PubMed ID: 21342043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in children with Ewing's sarcoma.
    Gehan EA; Nesbit ME; Burgert EO; Viettit J; Tefft M; Perez CA; Kissane J; Hempel C
    Natl Cancer Inst Monogr; 1981 Apr; (56):273-8. PubMed ID: 7029295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
    Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA
    J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison.
    Jenkin RD; Al-Fawaz I; Al-Shabanah M; Allam A; Ayas M; Khafaga Y; Memon M; Rifai S; Schultz H; Younge D
    Med Pediatr Oncol; 2002 Dec; 39(6):586-93. PubMed ID: 12376982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Megatherapy in children with high-risk Ewing's sarcoma in first complete remission.
    Madero L; Muñoz A; Sánchez de Toledo J; Díaz MA; Maldonado MS; Ortega JJ; Ramírez M; Otheo E; Benito A; Salas S
    Bone Marrow Transplant; 1998 Apr; 21(8):795-9. PubMed ID: 9603403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Donati D; Barbieri E; Forni C; Bertoni F; Manfrini M; Giacomini S; Bacchini P
    Oncol Rep; 2004 Jan; 11(1):111-20. PubMed ID: 14654912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.